These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 752014

  • 21. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J, Liebau G, Steiner B, Hayduk K.
    Klin Wochenschr; 1978 Sep 01; 56(17):859-64. PubMed ID: 713415
    [Abstract] [Full Text] [Related]

  • 22. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K, Fujishima S, Shionoiri H, Tochikubo O, Uneda S, Fujiki Y, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1984 Apr 01; 26(4):425-35. PubMed ID: 6381833
    [No Abstract] [Full Text] [Related]

  • 23. Hypertension associated with hyperparathyroidism is not responsive to angiotensin blockade.
    Zawada ET, Brickman AS, Maxwell MH, Tuck M.
    J Clin Endocrinol Metab; 1980 May 01; 50(5):912-5. PubMed ID: 6989846
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Acute effects of saralasin on plasma aldosterone in different pathophysiological conditions.
    Anderson GH, Anderson T, Streeten DH, Schroeder ET.
    J Clin Endocrinol Metab; 1980 Mar 01; 50(3):529-36. PubMed ID: 6987256
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T, Hata T, Maruyama A, Nakamaru M, Mikami H, Kumahara Y.
    Endocrinol Jpn; 1979 Oct 01; 26(5):591-7. PubMed ID: 393505
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M, Bichara M, Grüfeld JP, Barbanel C, Meyer P, Funck-Brentano JL.
    Nouv Presse Med; 1978 Feb 18; 7(7):539-43. PubMed ID: 643579
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical pharmacology of angiotensin antagonists.
    Pettinger WA, Mitchell HC.
    Fed Proc; 1976 Nov 18; 35(13):2521-5. PubMed ID: 976494
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.